Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
暂无分享,去创建一个
H T Lynch | J F Lynch | H. Lynch | C. Boland | S J Lanspa | C R Boland | P M Lynch | C L Snyder | Pm Lynch | SJ Lanspa | Clifford J. Snyder | JF Lynch
[1] D. Evans,et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations , 2009, Clinical genetics.
[2] R. Houlston,et al. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome. , 2009, Gastroenterology.
[3] Heather Hampel,et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] N. Marcon,et al. Missed Adenomas during Colonoscopic Surveillance in Individuals with Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) , 2008, Cancer Prevention Research.
[5] C. Boland,et al. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer. , 2008, Cancer research.
[6] K. Wimmer,et al. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? , 2008, Human Genetics.
[7] M. Bronner,et al. Identifying Lynch Syndrome: We Are All Responsible , 2008, Diseases of the colon and rectum.
[8] J. Potter,et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. , 2008, Gastroenterology.
[9] J. Klijn,et al. CHEK2 1100delC Is a Susceptibility Allele for HNPCC-Related Colorectal Cancer , 2008, Clinical Cancer Research.
[10] J. Mecklin,et al. The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome , 2008, International journal of cancer.
[11] F. Collins,et al. Keeping pace with the times--the Genetic Information Nondiscrimination Act of 2008. , 2008, The New England journal of medicine.
[12] M. Kloor,et al. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. , 2008, Gastroenterology.
[13] B. Bellosillo,et al. A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[14] Shuying Sun,et al. Origins and prevalence of the American Founder Mutation of MSH2. , 2008, Cancer research.
[15] P. Peltomäki,et al. Lynch syndrome and related familial colorectal cancers. , 2008, Critical reviews in oncogenesis.
[16] Esa Läärä,et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. , 2007, Gastroenterology.
[17] Peter R. Thom,et al. Ethical and legal aspects of cancer genetic testing. , 2007, Seminars in oncology.
[18] H. Morreau,et al. Molecular Analysis of Colorectal Cancer Tumors from Patients with Mismatch Repair–Proficient Hereditary Nonpolyposis Colorectal Cancer Suggests Novel Carcinogenic Pathways , 2007, Clinical Cancer Research.
[19] N. Suzuki,et al. Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer , 2007, Gut.
[20] D. Gilchrist,et al. Constitutive deficiency in DNA mismatch repair: is it time for Lynch III? , 2007, Clinical genetics.
[21] M. Urioste,et al. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. Jass. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.
[23] Jukka-Pekka Mecklin,et al. Explaining the Familial Colorectal Cancer Risk Associated with Mismatch Repair (MMR)-Deficient and MMR-Stable Tumors , 2007, Clinical Cancer Research.
[24] H. Hollema,et al. Early Carcinogenic Events in HNPCC Adenomas: Differences with Sporadic Adenomas , 2001, Digestive Diseases and Sciences.
[25] D. Chang,et al. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside , 2007, Familial Cancer.
[26] J. Kładny,et al. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? , 2007, European Journal of Human Genetics.
[27] H. Lynch,et al. Clinical selection of candidates for mutational testing for cancer susceptibility. , 2006, Oncology.
[28] G. Petersen,et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. , 2006, JAMA.
[29] Ewout W Steyerberg,et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. , 2006, JAMA.
[30] A. Whittemore,et al. Predicting and preventing hereditary colorectal cancer. , 2006, Journal of the American Medical Association (JAMA).
[31] G. Parmigiani,et al. Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomothearapy , 2009, Radiation oncology.
[32] P. Radice,et al. A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. , 2006, Cancer research.
[33] J. Cubiella,et al. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer , 2005, Gut.
[34] C. Boland,et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications , 2006, European Journal of Human Genetics.
[35] J. Kleibeuker,et al. Decrease in mortality in Lynch syndrome families because of surveillance. , 2006, Gastroenterology.
[36] M. Munsell,et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. , 2006, The New England journal of medicine.
[37] L. Aaltonen,et al. CHEK2 I157T associates with familial and sporadic colorectal cancer , 2005, Journal of Medical Genetics.
[38] J. Stockman. Conversion Analysis for Mutation Detection in MLH1 and MSH2 in Patients With Colorectal Cancer , 2006 .
[39] Prof. H. Luschka. Ueber polypöse Vegetationen der gesammten Dickdarmschleimhaut , 2006, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.
[40] R. Gafà,et al. Microsatellite Instability and Colorectal Cancer Prognosis , 2005, Clinical Cancer Research.
[41] L. Aaltonen,et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. , 2005, JAMA.
[42] A. Roca,et al. Differential Features of Colorectal Cancers Fulfilling Amsterdam Criteria without Involvement of the Mutator Pathway , 2005, Clinical Cancer Research.
[43] S. Cross,et al. The Role of High-Magnification-Chromoscopic Colonoscopy in Hereditary Nonpolyposis Colorectal Cancer Screening: A Prospective “Back-to-Back” Endoscopic Study , 2005, The American Journal of Gastroenterology.
[44] P. Laurent-Puig,et al. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[45] C. Turnbull,et al. Genetic predisposition to cancer. , 2005, Clinical medicine.
[46] A. de la Chapelle,et al. Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. , 2005, Gastroenterology.
[47] R. Fishel,et al. Lynch syndrome: form, function, proteins, and basketball. , 2005, Gastroenterology.
[48] P. Devilee,et al. Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype , 2005, The Journal of pathology.
[49] W. Frankel,et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.
[50] J. Potter,et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. , 2005, JAMA.
[51] Prathap Bandipalliam. Syndrome of Early Onset Colon Cancers, Hematologic Malignancies & Features of Neurofibromatosis in HNPCC Families with Homozygous Mismatch Repair Gene Mutations , 2005, Familial Cancer.
[52] M. Nooij,et al. Survival of Patients with Ovarian Cancer due to a Mismatch Repair Defect , 2005, Familial Cancer.
[53] J. Lubiński,et al. CHEK2 is a multiorgan cancer susceptibility gene. , 2004, American journal of human genetics.
[54] F. Collins,et al. The family history--more important than ever. , 2004, The New England journal of medicine.
[55] K. Offit,et al. The "duty to warn" a patient's family members about hereditary disease risks. , 2004, JAMA.
[56] M. Roncalli,et al. Re: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[57] P. Møller,et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. , 2004, Gastroenterology.
[58] H. Morreau,et al. Survival after adjuvant 5‐FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer , 2004, International journal of cancer.
[59] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[60] A. de la Chapelle,et al. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. , 2004, JAMA.
[61] R. Weksberg,et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. , 2004, Gastroenterology.
[62] C. Behling,et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. , 2004, Gastroenterology.
[63] M. Bisgaard,et al. The incidence rate of familial adenomatous polyposis , 1996, International Journal of Colorectal Disease.
[64] A. Umar,et al. Comment on: Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (lynch syndrome) and microsatellite instability. Author's reply , 2004 .
[65] S. Thibodeau,et al. Use of Microsatellite Instability and Immunohistochemistry Testing for the Identification of Individuals at Risk for Lynch Syndrome , 2004, Familial Cancer.
[66] P. Peltomäki. Lynch Syndrome Genes , 2004, Familial Cancer.
[67] C. Boland,et al. Evolution of the Nomenclature for the Hereditary Colorectal Cancer Syndromes , 2004, Familial Cancer.
[68] M. Ducreux,et al. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. , 2003, Cancer research.
[69] H. Nakagawa,et al. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques , 2003, Human mutation.
[70] L. Aaltonen,et al. Little evidence for involvement of MLH3 in colorectal cancer predisposition , 2003, International journal of cancer.
[71] J. Church,et al. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). , 2003, Diseases of the colon and rectum.
[72] Daniel J Sargent,et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.
[73] A. de la Chapelle,et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. , 2003, American journal of human genetics.
[74] S. Woolf,et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.
[75] P. Gregersen,et al. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. , 2002, American journal of human genetics.
[76] A. Duval,et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.
[77] P. Parfrey,et al. Impact of Gender and Parent of Origin on the Phenotypic Expression of Hereditary Nonpolyposis Colorectal Cancer in a Large Newfoundland Kindred With a Common MSH2 Mutation , 2002, Diseases of the colon and rectum.
[78] A. Wagner,et al. A 10‐Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North‐American kindred , 2002, Genes, chromosomes & cancer.
[79] H. Hollema,et al. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation , 2002, Gut.
[80] Daniel J Sargent,et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[81] H. Hollema,et al. A role for MLH3 in hereditary nonpolyposis colorectal cancer , 2001, Nature Genetics.
[82] F. Praz,et al. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. , 2001, Cancer research.
[83] N. B. Atkin. Microsatellite instability , 2001, Cytogenetic and Genome Research.
[84] T. Smyrk,et al. Tumor‐infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma , 2001, Cancer.
[85] A. Lindblom,et al. Microsatellite Instability and hMLH1 and hMSH2 Expression Analysis in Familial and Sporadic Colorectal Cancer , 2001, Laboratory Investigation.
[86] H. Lynch. Family information service and hereditary cancer , 2001, Cancer.
[87] R Wender,et al. American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.
[88] L. Ricciardiello,et al. Steady-state regulation of the human DNA mismatch repair system , 2001, The Journal of biological chemistry.
[89] R. Chadwick,et al. Recurrent germline mutation in MSH2arises frequently de novo , 2000, Journal of medical genetics.
[90] David Joseph,et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer , 2000, The Lancet.
[91] L. Aaltonen,et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.
[92] James R. Eshleman,et al. Conversion of diploidy to haploidy , 2000, Nature.
[93] A. de la Chapelle,et al. Predictive genetic testing for hereditary non‐polyposis colorectal cancer: Uptake and long‐term satisfaction , 2000, International journal of cancer.
[94] S. Bull,et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. , 2000, The New England journal of medicine.
[95] A. Chapelle,et al. Conversion of diploidy to haploidy - Individuals susceptible to multigene disorders may now be spotted more easily. , 2000 .
[96] A. de la Chapelle,et al. Genetic susceptibility to non-polyposis colorectal cancer , 1999, Journal of medical genetics.
[97] A. Millar,et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. , 1999, The American journal of surgical pathology.
[98] C. Boland,et al. Mismatch repair proficiency and in vitro response to 5-fluorouracil. , 1999, Gastroenterology.
[99] H T Lynch,et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.
[100] T. Ozcelik,et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. , 1999, Cancer research.
[101] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[102] S N Thibodeau,et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. , 1998, Cancer research.
[103] T. Smyrk,et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members , 1998, Cancer.
[104] L. Aaltonen,et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.
[105] K. Do,et al. Morphology of sporadic colorectal cancer with DNA replication errors , 1998, Gut.
[106] M. Loda,et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. , 1997, Cancer research.
[107] A D Carothers,et al. Cancer risk associated with germline DNA mismatch repair gene mutations. , 1997, Human molecular genetics.
[108] Chapelle,et al. Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer. , 1996, American journal of human genetics.
[109] M. Hawn,et al. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine. , 1996, The Journal of clinical investigation.
[110] C. Boland,et al. Loss of DNA mismatch repair in acquired resistance to cisplatin. , 1996, Cancer research.
[111] R. Fodde,et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. , 1996, Gastroenterology.
[112] K. Kinzler,et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer , 1995, Nature Medicine.
[113] M. Hawn,et al. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. , 1995, Cancer research.
[114] F. Nagengast,et al. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) , 1995, The Lancet.
[115] J. Weissenbach,et al. Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome. , 1995, Journal of medical genetics.
[116] B. Vogelstein,et al. Genetic instability occurs in the majority of young patients with colorectal cancer , 1995, Nature Medicine.
[117] P. Karran,et al. DNA damage tolerance, mismatch repair and genome instability , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.
[118] R. Fleischmann,et al. Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.
[119] K. Kinzler,et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. , 1994, Cancer research.
[120] Sajeev P. Cherian,et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. , 1994, Cancer research.
[121] R. Fleischmann,et al. Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.
[122] D. Ward,et al. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.
[123] J. Jass,et al. Pathology of hereditary non-polyposis colorectal cancer. , 1994, Anticancer research.
[124] Robin J. Leach,et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.
[125] N. Copeland,et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.
[126] A. Lindblom,et al. Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer , 1993, Nature Genetics.
[127] Tomas A. Prolla,et al. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair , 1993, Nature.
[128] Darryl Shibata,et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.
[129] J. Weber,et al. Genetic mapping of a locus predisposing to human colorectal cancer. , 1993, Science.
[130] S N Thibodeau,et al. Microsatellite instability in cancer of the proximal colon. , 1993, Science.
[131] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[132] G. Thomas,et al. [Genetic predisposition to colorectal cancer]. , 1993, Annales de gastroenterologie et d'hepatologie.
[133] B. Ponder. Genetic predisposition to cancer. , 1991, British Journal of Cancer.
[134] J. Mecklin,et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.
[135] H T Lynch,et al. Hereditary colorectal cancer. , 1991, Seminars in oncology.
[136] F. C. Lucibello,et al. Localization of the gene for familial adenomatous polyposis on chromosome 5 , 1987, Nature.
[137] A. Sandberg,et al. Gardner syndrome in a man with an interstitial deletion of 5q. , 1986, American journal of medical genetics.
[138] F. Troncale,et al. Familial colonic cancer without antecedent polyposis. , 1984, Annals of internal medicine.
[139] H. Bussey,et al. Familial polyposis coli. , 1975, Pathology annual.
[140] M. Shaw,et al. Hereditary factors in cancer. Study of two large midwestern kindreds. , 1966, Archives of internal medicine.
[141] P. LOCKHART-MUMMERY. CANCER AND HEREDITY. , 1925 .
[142] A. S. Warthin. HEREDITY WITH REFERENCE TO CARCINOMA: AS SHOWN BY THE STUDY OF THE CASES EXAMINED IN THE PATHOLOGICAL LABORATORY OF THE UNIVERSITY OF MICHIGAN, 1895-1913 , 1913 .